| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
74,564 |
50,491 |
$3.24M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,935 |
6,896 |
$421K |
| G9920 |
Screening performed and negative |
10,864 |
10,801 |
$381K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,368 |
6,316 |
$357K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,154 |
4,137 |
$316K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,008 |
3,846 |
$204K |
| 99188 |
|
9,323 |
9,228 |
$189K |
| 92551 |
|
14,506 |
14,410 |
$177K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,437 |
2,414 |
$171K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,527 |
3,256 |
$140K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,687 |
1,664 |
$134K |
| 90649 |
|
469 |
467 |
$88K |
| 99173 |
|
14,423 |
14,339 |
$65K |
| 90686 |
|
5,128 |
5,089 |
$52K |
| 90700 |
|
4,230 |
4,195 |
$46K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,636 |
2,507 |
$39K |
| 90670 |
|
3,156 |
3,116 |
$34K |
| 90713 |
|
3,140 |
3,110 |
$34K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
961 |
959 |
$32K |
| 85018 |
|
14,582 |
14,495 |
$27K |
| 90648 |
|
2,436 |
2,409 |
$27K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,003 |
1,995 |
$26K |
| D1206 |
Topical application of fluoride varnish |
1,137 |
1,122 |
$25K |
| 90716 |
|
2,164 |
2,147 |
$23K |
| 90633 |
|
2,055 |
2,036 |
$22K |
| 90707 |
|
2,046 |
2,037 |
$22K |
| 90744 |
|
1,849 |
1,811 |
$20K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
639 |
623 |
$20K |
| 90680 |
|
1,678 |
1,644 |
$18K |
| 90651 |
|
1,670 |
1,660 |
$17K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
309 |
303 |
$12K |
| 90621 |
|
606 |
605 |
$11K |
| 90715 |
|
1,033 |
1,030 |
$11K |
| 90734 |
|
989 |
983 |
$10K |
| 90619 |
|
737 |
733 |
$8K |
| 99381 |
|
83 |
81 |
$8K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,539 |
1,538 |
$5K |
| 90698 |
|
458 |
437 |
$5K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
2,484 |
2,403 |
$4K |
| 90677 |
|
329 |
324 |
$4K |
| 99383 |
|
25 |
25 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
25 |
25 |
$3K |
| 83655 |
|
241 |
234 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
204 |
203 |
$1K |
| 97802 |
|
1,413 |
1,412 |
$1K |
| G9919 |
Screening performed and positive and provision of recommendations |
38 |
38 |
$1K |
| 99442 |
|
36 |
34 |
$1K |
| 90658 |
|
108 |
108 |
$1K |
| 90660 |
|
116 |
116 |
$1K |
| J7612 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
107 |
106 |
$727.94 |
| 90657 |
|
45 |
45 |
$555.72 |
| 90655 |
|
42 |
42 |
$472.50 |
| 86580 |
|
70 |
67 |
$235.20 |
| 90647 |
|
16 |
16 |
$168.75 |
| 4004F |
|
277 |
277 |
$156.78 |
| 81001 |
|
74 |
67 |
$156.64 |
| 90710 |
|
12 |
12 |
$56.25 |
| 0001A |
|
13 |
13 |
$0.00 |
| 3008F |
|
249 |
249 |
$0.00 |
| 0002A |
|
16 |
16 |
$0.00 |